期刊文献+

中国胰腺神经内分泌肿瘤诊疗指南(2020) 被引量:17

The Chinese Guidelines for the Diagnosis and Treatment of Pancreatic Neuroendocrine Neoplasms(2020)
下载PDF
导出
摘要 胰腺神经内分泌肿瘤具有高度异质性,患者的临床管理存在一定难度。为了应对这一挑战,中华医学会外科学分会胰腺外科学组牵头成立了由肿瘤外科、消化内科、肿瘤内科、内分泌科、影像科、病理科、核医学科等多领域学者组成的专家委员会。该委员会回顾了与胰腺神经内分泌肿瘤诊断和治疗相关的重要问题,并基于循证医学证据提出了相应的诊疗建议,以期进一步改进中国胰腺神经内分泌肿瘤患者的诊疗流程。 Pancreatic neuroendocrine neoplasms(pNENs)are highly heterogeneous,and the manage⁃ment of pNENs patients can be intractable.To address this challenge,an expert committee was established on behalf of the Chinese Pancreatic Surgery Association,Chinese Society of Surgery,Chinese Medical Association,which consisted of surgical oncologists,gastroenterologists,medical oncologists,endocrinologists,radiologists,pathologists,and nuclear medicine specialists.By reviewing the important issues regarding the diagnosis and treatment of pNENs,the committee concluded evidence⁃based statements and recommendations in this article,in order to further improve the management of pNENs patients in China.
作者 吴文铭 陈洁 白春梅 依荷芭丽·迟 杜奕奇 冯仕庭 霍力 姜玉新 李景南 楼文晖 罗杰 邵成浩 沈琳 王峰 王理伟 王鸥 王于 吴焕文 邢小平 徐建明 薛华丹 薛玲 杨扬 虞先濬 原春辉 赵宏 朱雄增 赵玉沛 中华医学会外科学分会胰腺外科学组 WU Wenming;CHEN Jie;BAI Chunmei;YIHEBALI Chi;DU Yiqi;FENG Shiting;HUO Li;JIANG Yuxin;LI Jingnan;LOU Wenhui;LUO Jie;SHAO Chenghao;SHEN Lin;WANG Feng;WANG Liwei;WANG Ou;WANG Yu;WU Huanwen;XING Xiaoping;XU Jianming;XUE Huadan;XUE Ling;YANG Yang;YU Xianjun;YUAN Chunhui;ZHAO Hong;ZHU Xiongzeng;ZHAO Yupei;Chinese Pancreatic Surgery Association,Chinese Society of Surgery,Chinese Medical Association(Department of General Surgery,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China;Department of Gastroenterology,the First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China;Department of Medical Oncology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China;Department of Medical Oncology,National Cancer Center,National Clinical Research Center for Cancer,Cancer Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100021,China;Department of Gastroenterology,Changhai Hospital Affiliated to Navy Medical University,Shanghai 200433,China;Department of Radiology,the First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China;Department of Nuclear Medicine,Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China;Department of Ultrasound,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China;Department of Gastroenterology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China;Department of General Surgery,Zhongshan Hospital of Fudan University,Shanghai 200032,China;Department of Pathology,China-Japan Friendship Hospital,Beijing 100029,China;Department of Pancreatic-biliary Surgery,Changzheng Hospital,Navy Medical University,Shanghai 200003,China;Department of Gastrointestinal Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Nuclear Medicine,Nanjing First Hospital,Nanjing Medical University,Nanjing 210029,China;Department of Oncology,Renji Hospital,Shanghai JiaoTong University School of Medicine,Shanghai 200127,China;Department of Endocrinology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China;Department of Interventional Oncology,the First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China;Department of Pathology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China;Department of Gastrointestinal Oncology,the Fifth Medical Center,Chinese People's Liberation Army General Hospital,Beijing 100071,China;Department of Radiology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China;Department of Pathology,the First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China;Department of Hepatic Surgery and Liver Transplantation Center,the Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,China;Department of Pancreatic Surgery,Peking University Third Hospital,Beijing 100191,China;Department of General Surgery,Peking University Third Hospital,Beijing 100191,China;Department of Hepatobiliary Surgery,National Cancer Center,National Clinical Research Center for Cancer,Cancer Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100021,China;Department of Pathology,Fudan University Shanghai Cancer Center,Shanghai 200032,China;不详)
机构地区 中国医学科学院北京协和医学院北京协和医院基本外科疑难重症及罕见病国家重点实验室 中山大学附属第一医院消化内科 中国医学科学院北京协和医学院北京协和医院肿瘤内科 国家癌症中心国家肿瘤临床医学研究中心中国医学科学院北京协和医学院肿瘤医院肿瘤内科 海军军医大学附属长海医院消化内科 中山大学附属第一医院放射诊断科 中国医学科学院北京协和医学院北京协和医院核医学科核医学分子靶向诊疗北京市重点实验室 中国医学科学院北京协和医学院北京协和医院超声医学科 中国医学科学院北京协和医学院北京协和医院消化内科 复旦大学附属中山医院普外科 中日友好医院病理科 海军军医大学附属长征医院普通外科 北京大学肿瘤医院消化肿瘤内科恶性肿瘤发病机制及转化研究重点实验室 南京市第一医院核医学科 上海交通大学医学院附属仁济医院肿瘤科 中国医学科学院北京协和医学院北京协和医院内分泌科 中山大学附属第一医院肿瘤介入科 中国医学科学院北京协和医学院北京协和医院病理科 解放军总医院第五医学中心消化肿瘤内科 中国医学科学院北京协和医学院北京协和医院放射科 中山大学附属第一医院病理科 中山大学附属第三医院肝移植中心 复旦大学附属肿瘤医院胰腺外科 北京大学第三医院普通外科 国家癌症中心国家肿瘤临床医学研究中心中国医学科学院北京协和医学院肿瘤医院肝胆外科 复旦大学附属肿瘤医院病理科 不详
出处 《协和医学杂志》 CSCD 2021年第4期460-480,共21页 Medical Journal of Peking Union Medical College Hospital
基金 中国医学科学院医学与健康科技创新工程(2017⁃I2M⁃1⁃001)。
关键词 胰腺肿瘤 指南 诊断 治疗 pancreatic neoplasms guidelines diagnosis therapy
  • 相关文献

参考文献7

二级参考文献44

  • 1LIU Hong ZHANG Su-zhan WU Yu-lian FANG He-qing LI Jiang-tao SHENG Hong-wei WANG Yong.Diagnosis and surgical treatment of pancreatic endocrine tumors in 36 patients:a single-center report[J].Chinese Medical Journal,2007(17):1487-1490. 被引量:11
  • 2Siegel R,Naishadham D, Jemal A. Cancer statistics, 2012. CACancer J Clin, 2012,2:10-29.
  • 3Vincent A,Herman J,Schulick R,et al. Pancreatic cancer. Lancet,2011,378:607-620.
  • 4Howlader N,Noone AM,Krapcho M,et al. SEER Cancer StatisticsReview, 1975-2010, National Cancer Institute. Bethesda, MD.http://seer.cancer.gov/csr/1975_2010/results_merged/sect_22_pancreas.pdf. Accessed May 17,2013.
  • 5Lynn M. Matrisian,Rhonda Aizenberg, Aliison Rosenzweig. Thealarming rise of pancreatic cancer deaths in the United StatesiWhywe need to stem the tide today, http://www.pancan.org/section_research/reports/pd?/incidence_report_2012.pdf. PublishedAugust 2012. Accessed May 17,2013.
  • 6Conlon KC,Klimstra DS,Brennan MF. Long-term survival aftercurative r^sectionfor pancreatic ductal adenocarcinoma: clinico-pathologicanalysis of 5-year survivors. Ann Surg, 1996,223:273-279.
  • 7Varadhachary GR,Tamm EP,Abbruzzese JL,et al. Borderlineresectable pancreatic cancer: definitions, management, and role ofpreoperative therapy. Ann Surg Oncol, 2006,13:1035-1046.
  • 8Bilimoria KY,Talamonti MS, Sener SF,et al. Effect of hospitalvolume on margin status after pancreaticoduodenectomy forcancer. J Am Coll Surg, 2008,7:510-519.
  • 9Hernandez J, Mullinax J, Clark W, et al.Survival after pancrea-ticoduodenectomy is not improved by extending resections toachieve negative margins. Ann Surg, 2009,50:76-80.
  • 10Tamm EP, Balachandran A, Bhosale PR,et al. Imaging ofpancreatic adenocarcinoma : update on staging/resectability.Radiol Clin North Am, 2012,50:407-428.

共引文献133

同被引文献103

引证文献17

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部